Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

This represented 440,749 individuals who met Kidney Disease Improving Global Outcomes (KDIGO) clinical CKD criteria, ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

At the American College of Cardiology 2025 Annual Scientific Session, John W. Ostrominski, MD, of Brigham and Women’s Hospital, dives into the nuanced safety profile of finerenone for high-risk ...

The 2024 KDIGO guidelines for chronic kidney disease (CKD) emphasize using cystatin C for more accurate glomerular filtration rate (GFR) assessment, especially when creatinine is insufficient.

"The paper does a nice job highlighting the major changes in CKD care the new KDIGO guidelines will lead to," he said. Of note, "the recommendation to increase the use of cystatin C (in addition ...

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source ...

The Kidney Disease: Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney disease (CKD) management. The Kidney Disease ...

The full guideline included 28 recommendations for which there is the greatest evidence and 141 practice points, which reflect the expert opinion of the group. HealthDay News — In a 2024 ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Updated ...